ArticleScientific reports2026

Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer.

Anisha Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.